[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-371087-105":59,"doc-detail-371087-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-metabolic-crossroads-glycolysis-in-cancer-and-neurodegeneration","The metabolic crossroads: glycolysis in cancer and neurodegeneration","","Study investigates the biological basis of an epidemiological inverse relationship between cancer and neurodegenerative diseases, including Parkinson’s disease and Alzheimer’s disease. Single-cell and bulk RNA-sequencing data from TCGA and GEO are integrated to characterize metabolic alterations in colon adenocarcinoma and Parkinson’s disease, with human tissue validation by immunohistochemistry and in vitro functional assays. Glycolysis shows opposite regulation in colorectal cancer versus neurodegeneration, highlighting ACAA2 as a mediator.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-metabolic-crossroads-glycolysis-in-cancer-and-neurodegeneration/371087/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-metabolic-crossroads-glycolysis-in-cancer-and-neurodegeneration/371087.png","ImageObject",300,407,{"name":92,"@type":93},"hdkawk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What paradox does the study focus on?","Question",{"text":112,"@type":113},"The study addresses an inverse epidemiological relationship between cancer and neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were metabolic changes analyzed?",{"text":117,"@type":113},"The work integrates single-cell and bulk RNA-sequencing datasets from TCGA and GEO to assess metabolic alterations in colon adenocarcinoma and Parkinson’s disease.",{"name":119,"@type":110,"acceptedAnswer":120},"Which gene and metabolic pathway are highlighted in the results?",{"text":121,"@type":113},"Divergent glycolysis regulation is observed, with ACAA2 upregulated in Parkinson’s disease and more strongly in Alzheimer’s disease, while frequently downregulated in cancers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},371087,1790224763,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985747859855,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Zeng et al. BMC Neurology (2026) 26:9 [https://doi.org/10.1186/s12883-025-04533-6](https://doi.org/10.1186/s12883-025-04533-6)  \nBMC Neurology  \nRESEARCH Open Access  \nThe metabolic crossroads: glycolysis in cancer and neurodegeneration  \nShaopeng Zeng 1†, Huan Liu 1†, Shilong Han 1, Jun Chen 1, Ying Yang 1* and Jing Zhang 1,2*  \nAbstract  \nBackground Emerging epidemiological data reveal a compelling inverse relationship between cancer and neurodegenerative diseases, including Parkinson’s disease (PD) and Alzheimer’s disease (AD) . The biological mechanisms underlying this paradox remain unclear. The aim of this study was to identify shared metabolic pathways that may mediate this inverse association.  \nMethods We integrated single-cell and bulk RNA sequencing data from TCGA and GEO databases to examine metabolic alterations in colon adenocarcinoma (COAD) and PD. Furthermore, we validated the expression of the critical gene in human tissue samples using immunohistochemistry and corroborated its functional roles through in vitro experimental assays.  \nResults Divergent regulation of glycolysis was observed between COAD and PD. A key finding was the upregulation of acetyl-CoA acyltransferase 2 (ACAA2) in PD and, more markedly, in AD, contrasting with its frequent downregulation in cancers. Functionally, ACAA2 overexpression has been demonstrated to inhibit glycolysis and inflammation in colorectal cancer and neurological models.  \nConclusions Our findings identify glycolysis as a shared but oppositely regulated pathway linking cancer and neurodegeneration. ACAA2 may serve as a molecular mediator of this metabolic divergence, offering new insights into disease crosstalk and potential therapeutic targets.  \nKeywords Neurodegenerative diseases, Cancer, Parkinson’s disease, Glycolysis, ACAA2  \n†Shaopeng Zeng and Huan Liu contributed equally to this work.  \n*Correspondence:  \nYing Yang [rebecca_yang@zju.edu.cn](rebecca_yang@zju.edu.cn)[ ](rebecca_yang@zju.edu.cn)Jing Zhang [jzhang1989@zju.edu.cn](jzhang1989@zju.edu.cn)  \n1Department of Pathology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China 2National Human Brain Bank for Health and Disease, Zhejiang University, Hangzhou, Zhejiang 310012, China  \nBackground  \nCancer and neurodegenerative diseases are leading causes of morbidity and mortality worldwide [1, 2]. At first glance, these two conditions appear to involve opposing biological processes: cancer is characterized by uncontrolled cell proliferation, while neurodegenerative diseases are marked by progressive cell death [3]. However, epidemiological studies reveal a significant antagonistic relationship between cancer and neurodegenerative diseases. Specifically, cancer survivors demonstrate lower rates of neurodegeneration whereas patients with neurodegenerative diseases like Parkinson’s disease (PD) and Alzheimer’s disease (AD) show reduced cancer incidence [4–7]. This paradoxical association suggests  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, ","cbCais5WUDcL03br","https://ap.wps.com/l/cbCais5WUDcL03br","pdf",6014910,18,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n## Cancer–neurodegeneration inverse association\n## Metabolic dysregulation and glucose metabolism","[{\"question\":\"What paradox does the study focus on?\",\"answer\":\"The study addresses an inverse epidemiological relationship between cancer and neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease.\"},{\"question\":\"How were metabolic changes analyzed?\",\"answer\":\"The work integrates single-cell and bulk RNA-sequencing datasets from TCGA and GEO to assess metabolic alterations in colon adenocarcinoma and Parkinson’s disease.\"},{\"question\":\"Which gene and metabolic pathway are highlighted in the results?\",\"answer\":\"Divergent glycolysis regulation is observed, with ACAA2 upregulated in Parkinson’s disease and more strongly in Alzheimer’s disease, while frequently downregulated in cancers.\"}]","The metabolic crossroads: glycolysis in cancer and neurodegeneration | PDF",1790191216,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5cf726bdfbaebe9fa1ea8e35e6e466fa.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1534acd2d82a4edd0d2181ce9c034e4.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/934a5415f5bb7fe1b96c2f7f0b2739b4.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/72a70141e573c19db035b699a2fadb71.webp",980,1306]